Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Medicines Company has a market cap of $410.8 million; its shares were traded at around $7.75 with and P/S ratio of 1.
MDCO is in the portfolios of Chuck Royce of Royce& Associates, Jim Simons of Renaissance Technologies LLC.
This is the annual revenues and earnings per share of MDCO over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of MDCO.
CEO Recent Trades:
- Sell:: Chairman & CEO Clive Meanwell sold 6,863 shares of MDCO stock on 02/22/2010 at the average price of 7.4, the price of the stock has increased by 4.73% since.
CFO Recent Trades:
- Sell:: Executive VP & CFO Glenn Sblendorio sold 1,914 shares of MDCO stock on 02/22/2010 at the average price of 7.4, the price of the stock has increased by 4.73% since.
This is the insider trade history vs. stock price of MDCO. For the complete insider trading history of MDCO, click here.
Directors and Officers Recent Trades:
- Sell:: VP, Chief Human Strategy Offic Leslie C Rohrbacker sold 345 shares of MDCO stock on 02/22/2010 at the average price of 7.4, the price of the stock has increased by 4.73% since.
- Sell:: Chief Accounting Officer William Bernard O'connor sold 543 shares of MDCO stock on 02/22/2010 at the average price of 7.4, the price of the stock has increased by 4.73% since.
- Sell:: Sr. VP & General Counsel Paul Michael Antinori sold 1,083 shares of MDCO stock on 02/22/2010 at the average price of 7.4, the price of the stock has increased by 4.73% since.
Subscribe RSS
RSS